Stay updated on ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial
Sign up to get notified when there's something new on the ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial page.

Latest updates to the ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check20 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check27 days agoChange DetectedThe page has removed a citation regarding the safety and tolerability of eptinezumab in patients with migraine, which was previously included.SummaryDifference0.5%
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the ALD403 migraine trial and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference24%
Stay in the know with updates to ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALD403 Safety, Efficacy, Pharmacokinetics Clinical Trial page.